1262108-14-4 Usage
General Description
Vistusertib, also known as AZD2014, is a potent and selective dual mTORC1 and mTORC2 inhibitor that has shown promising results in preclinical studies and early-phase clinical trials for the treatment of various cancers. It inhibits the activity of the mTOR protein, which plays a crucial role in regulating cell growth and proliferation. By targeting both mTOR complexes, Vistusertib has the potential to disrupt multiple signaling pathways involved in cancer development and progression. Clinical trials have demonstrated its efficacy in combination with other anticancer drugs, and further research is ongoing to evaluate its potential as a targeted therapy for a range of cancer types. Overall, Vistusertib shows promise as a novel treatment option for cancer patients.
Check Digit Verification of cas no
The CAS Registry Mumber 1262108-14-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,2,1,0 and 8 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1262108-14:
(9*1)+(8*2)+(7*6)+(6*2)+(5*1)+(4*0)+(3*8)+(2*1)+(1*4)=114
114 % 10 = 4
So 1262108-14-4 is a valid CAS Registry Number.
1262108-14-4Relevant articles and documents
SELECTIVE PROGESTERONE RECEPTOR MODULATORS (SPRM) AND STABILIZED ESTROGEN LEVEL IN PATIENT
-
Paragraph 0081; 0082; 0083, (2019/01/09)
The present invention is related to Selective Progesterone Receptor Modulators (SPRM) as described and defined herein, and covers the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of sexual hormone de
17-HYDROXY-17-PENTAFLUOROETHYL-ESTRA-4,9(10)-DIEN-11-ARYL DERIVATIVES, METHOD OF PRODUCTION THEREOF AND USE THEREOF FOR THE TREATMENT OF DISEASES
-
, (2012/04/23)
The invention relates to 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives of Formula I with progesterone antagonizing action and method of production thereof, use thereof for the treatment and/or prophylaxis of diseases and use thereo